Universal Institute Of Stem Cell Treatment is categorized under Medical Centers in Carson City, NV and active since 2008.
Universal Institute Of Stem Cell Treatment was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number by the NAICS.
If you are seeking more information, feel free to contact Peter Krahl at the company’s single location by writing to 318 N Carson Street # 208, Carson City, Nevada NV 89701 or by phoning (702) 953-9414. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Universal Institute Of Stem Cell Treatment |
| Contact Person: | Peter Krahl |
| Address: | 318 N Carson Street # 208, Carson City, Nevada 89701 |
| Phone Number: | (702) 953-9414 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Centers |
| Share This Business: |
Universal Institute Of Stem Cell Treatment was started in 2008 to provide professional Medical Centers under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Peter Krahl for inquiries that concern Universal Institute Of Stem Cell Treatment by calling the company number (702) 953-9414, as your correspondence is most welcome. Additionally, the physical location of the single location of Universal Institute Of Stem Cell Treatment can be found at the coordinates 39.16391,-119.76698 as well as the street address 318 N Carson Street # 208 in Carson City, Nevada 89701.
For its online presence, you may visit Universal Institute Of Stem Cell Treatment’s website at and engage with its social media outlets through on Twitter and on Facebook.